RT Journal Article
SR Electronic
A1 Zarifyan, Alla
T1 PARAMETER Study
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 28
SP 17
OP 17
DO 10.1177/1559897715611122
UL http://mdc.sagepub.com/content/15/28/17.1.abstract
AB Results of the PARAMETER study demonstrated that the angiotensin receptor neprilysin inhibitor LCZ696 reduced central aortic systolic and pulse pressure more effectively than olmesartan in older patients with systolic hypertension and arterial stiffness. Both treatments were safe and well tolerated without significantly variability in key safety parameters between the groups.